(a) Each physician associate shall engage in continuing medical education to maintain requisite knowledge and skills, either by:

1. (1) Maintaining national certification through the National Commission on Certification of Physician Assistants (NCCPA) or its successor organization; or
2. (2) Obtaining not less than 100 credit hours of approved continuing medical education (CME) activity, as defined in RSA 328-D:1, I-a, in each renewal period, of which 40 credit hours shall be category 1 CME, and no more than 60 credit hours of which shall be in category II CME as described in Med 402.01.

(b) Each physician associate shall demonstrate compliance with this section by submitting proof of national certification or CME credit hours with the renewal application.

Source. #14142, INTERIM, eff 12-5-24, EXPIRES: 6-3-25 (Remains in effect per RSA 541-A:14-a); ss by #14395, eff 10-2-25, EXPIRES: 10-2-35

APPENDIX I

RULE

STATUTE

Med 102.08

RSA 541-A:16, I(a)

Med 103.01

RSA 329:2, I; RSA 329:4

Med 103.02

RSA 329:2; RSA 329:3; RSA 329:7

Med 103.03

RSA 329:2, IV

Med 104.01

RSA 541-A:16, I(a)

Med 105.03

RSA 541-A:16, I(a)

Med 106.01

RSA 329:8, XVII

Med 107.01

RSA 329:8, XVII

Med 201.01

RSA 329:9, VI and XV

Med 201.02

RSA 541-A:16, I (b)

Med 301.01

RSA 541-A:7

Med 301.01(a)-(f)

RSA 329:9, XVI

Med 301.01(g)-(k)

RSA 329:9, I; 329:9, II; 329:12; 329:14, III

Med 301.02

RSA 329:9, I; RSA 329:12, I (b); RSA 329:14

Med 301.03

RSA 329:9, I; RSA 329:12, I (a) & (b); RSA 329:14;

RSA 161-B:11, VI-a

Med 301.03 intro to (a), (a)(1), (a)(3)-(a)(27) and (b)

RSA 329:12, I(a), (c)(4), (5) and (6), 329:14, II, 161-B:11, VI-a

Med 301.03(a)(2)

RSA 329:9, I, 329:9, II and 329:12

Med 301.03(a)(28) and (29)

RSA 329:9, I; 329:14, I

Med 301.03(c) & (d)(1)-(3)

RSA 329:14, II; 329:14, III

Med 301.04

RSA 329:9, IV; 329:16-h

Med 301.04(c), (d) and (e)

RSA 329:12, I(a) and (b); 329:14, II; 329:16-e

Med 302.01

RSA 329:9, II, RSA 329:12

Med 303.01

RSA 329:9, II; 329:12, I(d)(6)

Med 303.01(a), (b), (d)

RSA 329:12, I(d)(6)

Med 301.01(c)

RSA 329:12, II

Med 303.01(a)(1), (4) and (5)

RSA 329:9, III, 329:10, 329:11, 329:12(c)(6)

Med 303.01(a)(2), (3), and (b)-(c)

RSA 329:9, II, III; 329:10; 329:12, I(c)(6)

Med 303.02

RSA 329:9, II; RSA 329:12, I (d)(6); RSA 329:14, V(a)

Med 303.02(a) and (b)

RSA 329:9, III, 329:12, (c)(6)

Med 303.02(c)(1)-(3)

RSA 329:9, II, III; 329:14, V(a)

Med 305.01

RSA 329:9, I, II; RSA 329:14, VII

Med 305.01(a) - (d)

RSA 329:9, I, II, 329:14, VII

Med 305.02

RSA 329:9, I, II, VIII; RSA 329:14, VI

Med 305.03

RSA 329:9, I, II; RSA 329:14, VIII

Med 305.04

RSA 329:9, I, II; RSA 329:14, V(a)-(c)

Med 306.01

RSA 329:9, VII; RSA 329:12, I(a); RSA 329:16-a; RSA 329:16-h

Med 401.01

RSA 329:16-e; 329:16-a

Med 401.02

RSA 329:16-a

Med 401.02(c)

RSA 329:9, II, VII; 329:16-a, 329:16-c; 329:16-g

Med 401.03

RSA 161-B:11, VI-a; RSA 329:9, I, II; RSA 329:12, I(b);

RSA 329:16-a; RSA 329:16-c; RSA 329:16-f, I; RSA 329:16-g;

RSA 329:16-h; RSA 329:18, VI; RSA 318-B:33, II

Med 401.03(a)

RSA 329:9, VII; 329:12, I(a); 329:16-a; 329:16-h

Med 401.03(b) intro. and (b)(1)

RSA 329:9, II, 329:16-f, I; 329:16-a; 329:18, VI

Med 401.03(b)(2)-(6), (b)(14) & (15), (c) & (d)

RSA 329:9, II, VII, 329:16-a, 329:16-c, 329:16-g

Med 401.03(b)(7) & (b)(8)-(13)

RSA 329:9, I, II & V; 329:16-a

Med 401.03(b)(17)

RSA 161-B:11; 329:9, I; 329:16-a

Med 401.03(b)(18)

RSA 329:9, I; 329:16-a

Med 401.03(b)(19)

RSA 329:9, I; 329:16-a; 318-B:33, II

Med 401.03(e)

RSA 318-B:33, II; 329:9, II; 329:16-a;

Med 401.04

RSA 329:16-e

Med 401.05

RSA 329:9, II, VII, 329:16-e, 329:16-h

Med 401.05 (a) intro, (1) – (5)

RSA 329:9, II, VII; 329:16-e; 329:16-h

Med 401.05 (a) intro., (a)(4)-(5)

RSA 329:14, II; 329:9, II

Med 401.05 (a)(6)

RSA 329:9, II; 329:16-a; 318-B:33, II

Med 402.01

RSA 329:9, II; RSA 329:16-g

Med 402.02

RSA 329:9, II; RSA 329:16-g

Med 402.03

RSA 329:9, II; RSA 329:16-g

Med 403

RSA 329:16-f, 329:16-g

Med 403.01

RSA 541-A:16, I(b)

Med 403.02

RSA 541-A:16, I(b)

Med 403.03

RSA 329:9, II, V; RSA 329:16-f; RSA 329:16-g

Med 403.04

RSA 329:9, II; RSA 329:16-g

Med 403.05

RSA 329:9, II; RSA 541-A:16, I(a)

Med 407

RSA 329:13-b

Med 407.01

RSA 329:13-b; RSA 541-A:7; RSA 541-A:16, I (b), intro.

Med 407.02

RSA 329:13-b; RSA 541-A:16, I (b), intro.

Med 407.03

RSA 329:13-b; RSA 541-A:16, I (b), intro.

Med 408.01

RSA 329:9, IV; RSA 329:17, VII; RSA 329:17-c

Med 409.01

RSA 329:9, VI, XV, XVII-XIX; RSA 329:17

Med 410.01

RSA 329:9, VI, XV, XVII-XIX; RSA 329:17

Med 411.01 – 411.03

RSA 329:9, VX; 329:17, VII (g); RSA 329:2, II(d)

Med 412.01 – 412.02

RSA 329:9, IV

Med 412.03

RSA 329:9, IV, RSA 541-A:16, I(b)

Med 413.01

RSA 329:9, VI, XV, XVII-XIX; RSA 329:17

Med 413.02

RSA 329:9, IV, RSA 541-A:16, I(b)

Med 501.02

RSA 329:9, I, II, V, XV-a; RSA 329:2, II, (a), (b), (d),

RSA 329:12, I(b); RSA 329:14, II; RSA 329:17, VI(d);

RSA 318-B:33, II; RSA 318-B:36, III, IV, V

Med 501.01(b)

RSA 329:14, III, 329:24

Med 501.02

RSA 329:9, V

Med 501.02(a) & (b)

RSA 329:9, I, II & V

Med 501.02(c)-(i)

RSA 329:9, V, & XV-a

Med 501.02 (k)

RSA 329:2, II (b); 329:2, II (d); RSA 329:9, V; RSA 329:17, VI (d);

RSA 318-B:33, II

Med 501.02 (l)

RSA 329:2, II (d); RSA 329:9, V; RSA 329:17, VI (d);

RSA 318-B:33, II; RSA 329:2, II (a); RSA 329:12, I (b); RSA 329:14, II

Med 501.02 (m)

RSA 329:2, II (b); 329:2, II (d); RSA 329:9, V; RSA 329:17 VI Cd);

RSA 318-B:36, IV.

Med 501.02 (n)

RSA 329:2, II (b); RSA 329:2, II (d); RSA 329:9, V;

RSA 329:17, VI (d); RSA 318-B:36,V

Med 501.02 (o)

RSA 329:2, II (b); RSA 329:2, II (d); RSA 329:9, V;

RSA 329:17, VI (d); RSA 318-B:36, III

Med 502

RSA 329:9, V and XV-a

Med 502.03

RSA 329:9, V and XV-a; RSA 318-B:41, II(d)

Med 502.05

RSA 329:9, V and XV-a; RSA 318-B:41, II(d)

Med 601.01 – Med 601.07

RSA 328-D:1

Med 601.06

RSA 328-D:1

Med 601.02, Med 601.03

RSA 328-D:1

Med 601.05, Med 601.06

RSA 328-D:1

Med 602.01(a)

RSA 328-D:12

Med 602.01(b)

RSA 328-D:18

Med 602.02, Med 602.03

RSA 328-D:3-b

Med 601.07

RSA 328-D:1

Med 602.01

RSA 328-D:12

Med 602.01(a)

RSA 328-D:12

Med 602.01(b)

RSA 328-D:18

Med 602.02, Med 602.03

RSA 328-D:3-b, I

Med 603.01

RSA 328-D:10, I(a)

Med 604.01

RSA 328-D:3, RSA 328-D:10, I(b)

Med 605.01

RSA 328-D:3; RSA 328-D:10, I(e)

Med 606

Reserved

Med 607.01

RSA 328-D:5-a, I; RSA 328-D:10, I(c)

Med 608.01

RSA 328-D:5; RSA 328-D:10, I(c); RSA 318-B:33, II

Med 609.01

RSA 328-D:6; RSA 328-D:7; RSA 328-D:10, I(d) and (g)

Med 610.02

RSA 328-D:10, I(j)

Med 612.01

RSA 328-D, XIII

Med 613

RSA 328-D-10, I(m)

APPENDIX II

Med 501.02(h), Med 501.02(i)(4), Med 501.02(i)(5)

Med 501.02(h)

Code of Medical Ethics of the American Medical Association, Current Opinions with Annotations, 2012-2013 Edition. This document is available at the office of the Board of Medicine, 121 South Fruit Street, Concord, N.H. 03301 for a fee of $.25 per page.

Med 501.02(i)(4)

Federation of State Medical Boards Model Policy on the Use of Opioid Analgesics in the Treatment of Chronic Pain, July 2013. This document is available at the office of the Board of Medicine, 121 South Fruit Street, Concord, N.H. 03301 for a fee of $.25 per page.

Med 501.02(i)(5)

Clinical Guidelines for the Use of Buprenorphrine in the Treatment of Opioid Addiction, A Treatment Improvement Protocol by the U.S. Department of Health, and Human Services (2004), www.pcssmentor.org. This document is available at the office of the Board of Medicine, 121 South Fruit Street, Concord, N.H. 03301 for a fee of $.25 per page.

APPENDIX III INCORPORATED REFERENCES

Rule

Reference

Obtain at:

Med 501.02(h)

Code of Medical Ethics of the American Medical Association, Current Opinions with Annotations, June 2016 Edition.

Available at the office of the Board of Medicine, 121 South Fruit Street, Concord, N.H. 03301 for a fee of $.25 per page.

Med 502.06 (a)

The American Society of Addiction Medicine’s “National Practice Guideline For the Use of Medications in the Treatment of Addiction Involving Opioid Use,” adopted on June 1, 2015.

No cost to download from:

http://www.asam.org/docs/default-source/practice-support/guidelines-and-consensus-docs/asam-national-practice-guideline.pdf?sfvrsn=0

Med 502.07 (a)

The American Society of Addiction Medicine’s “National Practice Guideline For the Use of Medications in the Treatment of Addiction Involving Opioid Use,” adopted on June 1, 2015.

No cost to download from:

Med 609.01 (a) (8)

“Guidelines for Ethical Conduct for the Physician Assistant Profession” of the American Academy of Physician Assistants, adopted in 2000 and reaffirmed in 2013

No cost to download from:

https://www.aapa.org/wp-content/uploads/2017/02/16-EthicalConduct.pdf